Growth Metrics

Mannkind (MNKD) Long-Term Deferred Tax (2020 - 2025)

Mannkind (MNKD) reported Long-Term Deferred Tax of $41000.0 for Q4 2025, up 95.24% year-over-year from $21000.0 in Q4 2024, and up 95.24% on a QoQ basis from $21000.0 in Q4 2024.

Mannkind (MNKD) has 4 years of Long-Term Deferred Tax data on file, last reported at $41000.0 in Q4 2025.

  • Quarterly Long-Term Deferred Tax rose 95.24% year-over-year to $41000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $41000.0 (up 95.24% YoY) and the FY2025 annual result came in at $41000.0, up 95.24% from the prior year.
  • Long-Term Deferred Tax grew to $41000.0 in Q4 2025 per MNKD's latest filing, from $21000.0 in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $41000.0 in Q4 2025 and bottomed at $6000.0 in Q4 2023.
  • The 3-year median for Long-Term Deferred Tax is $21000.0 (2024), against an average of $22666.7.
  • The widest annual swing landed in 2024, when Long-Term Deferred Tax jumped 250.0%; it then soared 95.24% in 2025.
  • Tracing MNKD's Long-Term Deferred Tax over 3 years: stood at $6000.0 in 2023, then jumped by 250.0% to $21000.0 in 2024, then soared by 95.24% to $41000.0 in 2025.
  • Per Business Quant, the three latest MNKD Long-Term Deferred Tax figures stand at $41000.0 (Q4 2025), $21000.0 (Q4 2024), and $6000.0 (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 41,000.00
Dec 31, 2024 21,000.00
Dec 31, 2023 6,000.00
Sep 30, 2020 200,000.00